Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 118, Issue 8, Pages 1074-1083
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1038/s41416-018-0050-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1 -mutated or IDH2 -mutated solid tumours
- (2017) Remco J Molenaar et al. BMJ Open
- Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies
- (2016) Steve Pascolo EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line
- (2016) Yvonne de Jong et al. LABORATORY INVESTIGATION
- Targeting survivin as a potential new treatment for chondrosarcoma of bone
- (2016) Y de Jong et al. Oncogenesis
- Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
- (2015) R. J. Molenaar et al. CANCER RESEARCH
- Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study
- (2015) Anna Maria Frezza et al. EUROPEAN JOURNAL OF CANCER
- Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4
- (2015) Sara R. Martins-Neves et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma
- (2015) Zuzanna Baranski et al. JOURNAL OF PATHOLOGY
- Prediction and validation of enzyme and transporter off-targets for metformin
- (2015) Sook Wah Yee et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
- (2015) Elisabet Cuyàs et al. Oncotarget
- Mesenchymal Chondrosarcoma of Bone and Soft Tissue: A Systematic Review of 107 Patients in the Past 20 Years
- (2015) Jie Xu et al. PLoS One
- Outcome of advanced, unresectable conventional central chondrosarcoma
- (2014) Annemiek M. van Maldegem et al. CANCER
- IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism
- (2014) A. R. Grassian et al. CANCER RESEARCH
- Estimated Cause-specific Survival Continues to Improve Over Time in Patients With Chondrosarcoma
- (2014) Kyle R. Duchman et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Hominoid-specific enzyme GLUD2 promotes growth ofIDH1R132Hglioma
- (2014) Ruihuan Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
- (2013) J G van Oosterwijk et al. BRITISH JOURNAL OF CANCER
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy
- (2013) Y.-X. Zhang et al. CLINICAL CANCER RESEARCH
- Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
- (2012) Jolieke G van Oosterwijk et al. BMC CANCER
- Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma
- (2012) Danielle Meijer et al. GENES CHROMOSOMES & CANCER
- Characterization of a New Human Cell Line (CH-3573) Derived from a Grade II Chondrosarcoma with Matrix Production
- (2012) Silvia Calabuig-Fariñas et al. PATHOLOGY & ONCOLOGY RESEARCH
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
- (2011) M Fernanda Amary et al. JOURNAL OF PATHOLOGY
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2
- (2011) M Fernanda Amary et al. NATURE GENETICS
- Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
- (2011) Twinkal C Pansuriya et al. NATURE GENETICS
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of -ketoglutarate to citrate to support cell growth and viability
- (2011) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours
- (2010) Stephane Boeuf et al. HISTOPATHOLOGY
- Autophagy: assays and artifacts
- (2010) Sandra Barth et al. JOURNAL OF PATHOLOGY
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- The Clinical Approach Towards Chondrosarcoma
- (2008) H. Gelderblom et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started